Psychological Distress Reported for Indolent Non-Hodgkin Lymphomas

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- Patients with indolent non-Hodgkin lymphomas (iNHL) report considerable psychological distress, according to a study published online Nov. 3 in The Oncologist.

Richard A. Newcomb, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a cross-sectional study of adults newly diagnosed with iNHL in the past three months and assessed quality of life, psychological symptoms, coping, and perception of prognosis.

Overall, 70.6 percent of 68 eligible patients were enrolled. The researchers found that the most common diagnoses were chronic lymphocytic leukemia and follicular lymphoma (39.6 and 33.3 percent, respectively). Of the patients, 27.1 and 14.6 percent reported clinically significant anxiety and symptoms of posttraumatic stress disorder (PTSD), respectively. Coping strategies at diagnosis included acceptance, seeking emotional support, and denial (56.2, 47.9, and 47.9 percent, respectively). Two-thirds of the patients recalled their oncologist assessment of illness as incurable, but only 35.4 percent reported that the illness was unlikely to be cured. Overall, 45.8 and 31.2 percent indicated being worried about their prognosis and reported perseverating on their prognosis, respectively. Fewer anxiety, depression, and PTSD symptoms and better quality of life were seen in association with higher emotional coping with prognosis.

"Interventions to address prognostic uncertainty and to promote positive emotional coping with prognosis in patients with iNHL are an unmet need and have the potential to ameliorate psychological distress and improve quality of life in this patient population," the authors write.

Two authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-22 02:51

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords